Testimonials For Scientific Advantage
"We have been extremely fortunate at Yamanouchi in having the support of Dr. Robin Winter-Sperry to establish and manage our Clinical Science Liaison function as we enter a new therapeutic area for Yamanouchi Pharma America. Her experience and knowledge in this important and challenging arena have been extremely valuable to our success in launching this important function in Yamanouchi. She is competent in the legally complex area of the Clinical Science Liaison function and effective in identifying and hiring candidates. I recommend her highly to any company starting such a function for the future success of your business."
------------------------------------------
Robert E. Desjardins , M.D.
Executive Vice President
Chief Development Officer, Euro-America
Yamanouchi Group Business LLC
"Under Dr. Robin Winter-Sperry's leadership, our MSL group saw unprecedented growth. Healthcare professionals (MD, Pharm.D., Ph.D.) joined Sanofi-Synthelabo to provide medical support for products in multiple therapeutics arenas - cardiovascular, internal medicine, and CNS. The credibility and productivity of this group has been instrumental in "impacting business through science." Robin's knowledge of the ever-changing dynamic of this industry, as well as her wealth of contacts, serve her well in guiding companies and individuals who wish to better understand critical success factors necessary for MSL groups."
------------------------------------------
Lucy Maa, Pharm.D.
Sr. Regional Medical Manager
Sanofi-Synthelabo, Inc.
"Kathy Gann has a wealth of experience and knowledge about the field-based medical position. I worked with Kathy as one of the core team members of the Drug Information Association (DIA) sub-group that developed programming for Field Based Medical Programs. Kathy's depth of experience in developing, expanding and integrating medical liaison teams at several companies was an asset to the team and gave her the necessary ability to speak confidently and credibly at multiple conferences. I also enjoyed working with Kathy because of her spirit and commitment to the success of field based programs and her desire to champion the continued success and development of these groups."
------------------------------------------
Donna Holder, PharmD
Director, Strategy Planning
Medical Affairs
AstraZeneca
"Marie Tartaglio led the team creating the Advanced Scientific Learning System for Medical Liaisons at AstraZeneca. She showed great creativity and dedication throughout the project and had a clear vision that she was able to communicate successfully to all team members, both at AstraZeneca and ETSI. The end result was a cutting edge program focused on the science needed for peer-to-peer interactions with healthcare providers. Working together, we delivered a program that exceeded the customers' expectations - on time, on budget, and on target!"
------------------------------------------
Mikki Fleming
Contracts Developer
ETSI